Your browser doesn't support javascript.
loading
Use of experimental medicine approaches for the development of novel psychiatric treatments based on orexin receptor modulation.
Beckenstrom, Amy C; Coloma, Preciosa M; Dawson, Gerard R; Finlayson, Ailidh K; Malik, Asad; Post, Anke; Steiner, Michel Alexander; Potenza, Marc N.
Afiliação
  • Beckenstrom AC; P1vital Ltd, Manor House, Howbery Business Park, Wallingford OX10 8BA, UK. Electronic address: abeckenstrom@p1vital.com.
  • Coloma PM; Idorsia Pharmaceuticals Ltd, Hegenheimermattweg 91, Allschwil 4123, Switzerland.
  • Dawson GR; P1vital Ltd, Manor House, Howbery Business Park, Wallingford OX10 8BA, UK.
  • Finlayson AK; P1vital Ltd, Manor House, Howbery Business Park, Wallingford OX10 8BA, UK; Department of Psychology, University of Bath, Claverton Down, Bath BA2 7AY, UK.
  • Malik A; P1vital Ltd, Manor House, Howbery Business Park, Wallingford OX10 8BA, UK.
  • Post A; Corlieve Therapeutics, Swiss Innovation Park, Hegenheimermattweg 167A, 4123 Allschwil, Switzerland.
  • Steiner MA; Idorsia Pharmaceuticals Ltd, Hegenheimermattweg 91, Allschwil 4123, Switzerland.
  • Potenza MN; Departments of Psychiatry and Neuroscience and the Child Study Center, Yale School of Medicine, 1 Church Street, Room 726, New Haven, CT 06510, USA; Connecticut Mental Health Center, 34 Park Street, New Haven, CT 06519, USA; Connecticut Council on Problem Gambling, Wethersfield, CT, USA; The Wu Tsai
Neurosci Biobehav Rev ; 147: 105107, 2023 04.
Article em En | MEDLINE | ID: mdl-36828161

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neuropeptídeos / Pesquisa Biomédica / Transtornos Mentais Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neuropeptídeos / Pesquisa Biomédica / Transtornos Mentais Idioma: En Ano de publicação: 2023 Tipo de documento: Article